Skip to main content
Erschienen in: Diabetologia 6/2007

Open Access 01.06.2007 | Review

The role of physical activity in the management of impaired glucose tolerance: a systematic review

verfasst von: T. Yates, K. Khunti, F. Bull, T. Gorely, M. J. Davies

Erschienen in: Diabetologia | Ausgabe 6/2007

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Although physical activity is widely reported to reduce the risk of type 2 diabetes in individuals with prediabetes, few studies have examined this issue independently of other lifestyle modifications. The aim of this review is to conduct a systematic review of controlled trials to determine the independent effect of exercise on glucose levels and risk of type 2 diabetes in people with prediabetes (IGT and/or IFG). A detailed search of MEDLINE (1966–2006) and EMBASE (1980–2006) found 279 potentially relevant studies, eight of which met the inclusion criteria for this review. All eight studies were controlled trials in individuals with impaired glucose tolerance. Seven studies used a multi-component lifestyle intervention that included exercise, diet and weight loss goals and one used a structured exercise training intervention. Four studies used the incidence of diabetes over the course of the study as an outcome variable and four relied on 2-h plasma glucose as an outcome measure. In the four studies that measured the incidence of diabetes as an outcome, the risk of diabetes was reduced by approximately 50% (range 42–63%); as these studies reported only small changes in physical activity levels, the reduced risk of diabetes is likely to be attributable to factors other than physical activity. In the remaining four studies, only one reported significant improvements in 2-h plasma glucose even though all but one reported small to moderate increases in maximal oxygen uptake. These results indicate that the contribution of physical activity independent of dietary or weight loss changes to the prevention of type 2 diabetes in people with prediabetes is equivocal.
Abkürzungen
ADA
American Diabetes Association
DPP
Diabetes Prevention Program
FDPS
Finnish Diabetes Prevention Study
MeSH
medical search headings

Introduction

Given the growing prevalence of diabetes and the high economic cost of treating the condition and its comorbities, it is important to find effective ways of targeting those who are most at risk of developing the disease [1]. Prediabetes is the collective term for people with IGT and/or IFG [2]. Prediabetes is associated with an increased risk of development of type 2 diabetes [3] and cardiovascular disease [46]. There is good evidence from cross-sectional and longitudinal studies for a link between levels of physical activity and the risk of type 2 diabetes [79]. However, evidence from intervention studies in high-risk populations is limited, making it difficult to quantify the effectiveness of physical activity in reducing the risk of type 2 diabetes in individuals with prediabetes. Lifestyle intervention studies that have encouraged weight loss through a combination of dietary change and increased physical activity have reduced the risk of type 2 diabetes in individuals with IGT [1014]. However, because physical activity was not usually analysed independently of other variables, such as weight loss, it is difficult to determine the effectiveness of physical activity at protecting against the risk of diabetes in individuals with prediabetes. Therefore, the aim of this systematic review is to establish the effectiveness of physical activity independent of other variables at reducing the risk of diabetes or improving glucose parameters in people with prediabetes.

Materials and methods

Search strategy
MEDLINE (1966 to February week 4, 2006) and EMBASE (1980 to week 8, 2006) were searched for articles examining the effect of an exercise or lifestyle intervention on individuals with prediabetes. The search was carried out using medical search headings (MeSH) and by searching titles and abstracts for relevant words. For example, studies including individuals with prediabetes were found by using the MeSH ‘prediabetic state,’ ‘insulin resistance,’ ‘glucose intolerance’ and ‘diabetes mellitus’ (subheading ‘prevention and control’), and by searching titles and abstracts for ‘prediabetes,’ ‘impaired glucose tolerance,’ ‘IGT,’ ‘impaired fasting glucose’ and ‘IFG.’ Studies that included an exercise intervention were found by using the MeSH ‘lifestyle,’ ‘sports,’ ‘exercise therapy’ and ‘physical fitness,’ and by searching titles and abstracts for ‘exercise,’ ‘physical activity,’ ‘physical fitness,’ ‘resistance training,’ ‘strength training,’ ‘circuit training,’ ‘endurance training’ and ‘aerobic training.’ In addition, the reference lists of relevant published original articles and reviews were hand-searched.
One reviewer (T. Yates) performed the electronic and hand-searches and reviewed the results. Studies that clearly did not meet the inclusion criteria were rejected during the initial review. Where uncertainty existed, the full text of the article was obtained and reviewed. Two reviewers (T. Yates and K. Khunti) independently assessed all potentially relevant studies and performed data extraction. Disagreement was resolved by discussion and, where necessary, third party adjudication.
Subjects
Participants were adults (age ≥18 years) diagnosed with prediabetes. Prediabetes was defined as IGT and/or IFG using one of the sets of criteria previously recommended by the WHO [15, 16] or the American Diabetes Association (ADA) [17, 18]. Studies that defined IGT or IFG using other criteria were included if the mean value of the participants’ plasma glucose fell within the range of IGT or IFG as defined by the WHO or ADA criteria (2-h plasma glucose ≥7.8 mmol/l and <11.1 mmol/l, and fasting glucose <7.8 mmol/l for IGT; 2-h plasma glucose <7.8 mmol/l, and fasting glucose ≥5.6 mmol/l and <7.0 mmol/l for IFG).
Interventions
Interventions that included an exercise programme were included. ‘Exercise programme’ was taken to mean any intervention that actively promoted and supported physical activity or a structured exercise training regimen. Studies that only provided individuals with brief written or verbal physical activity advice were excluded. Studies investigating the effect of a single or acute episode of exercise were also excluded.
Outcome measures
Only studies with an outcome measure of physical activity and a relevant clinical measure were included. A relevant clinical measure was defined as progression to diabetes or a suitable measure of plasma glucose (2-h plasma glucose for IGT, or fasting glucose for IFG).
Type of study
Randomised and non-randomised controlled trials were included.
Analysis
As the heterogeneity of the type of exercise interventions and outcome measures did not lend itself to quantitative methods of analysis, a systematic narrative review was undertaken. Baseline and follow-up exercise, body mass and glucose parameters were reported using mean±SEM, or median (interquartile range). Results reporting the SD or the 95% CI were converted to SEM using the formulas \( {\text{SEM}} = {{\text{SD}}} \mathord{\left/ {\vphantom {{{\text{SD}}} {\surd {\text{n}}\,{\text{and}}\,{\text{SEM}} = {{\left( {{\text{CI}}_{{{\text{upper}}}} - {\text{CI}}_{{{\text{lower}}}} } \right)}} \mathord{\left/ {\vphantom {{{\left( {{\text{CI}}_{{{\text{upper}}}} - {\text{CI}}_{{{\text{lower}}}} } \right)}} {2t}}} \right. \kern-\nulldelimiterspace} {2t}}}} \right. \kern-\nulldelimiterspace} {\surd {\text{n}}\,{\text{and}}\,{\text{SEM}} = {{\left( {{\text{CI}}_{{{\text{upper}}}} - {\text{CI}}_{{{\text{lower}}}} } \right)}} \mathord{\left/ {\vphantom {{{\left( {{\text{CI}}_{{{\text{upper}}}} - {\text{CI}}_{{{\text{lower}}}} } \right)}} {2t}}} \right. \kern-\nulldelimiterspace} {2t}} \) (where t is the t distribution value for a 95% CI), respectively. Where the SEM, SD or 95% CI for the change from baseline to follow-up was not reported, only the mean value is reported because of the potential error involved in calculating SEM for this figure. When available, the relative risk of diabetes in the intervention group compared with the control group was also reported.

Results

The search produced 307 hits, from which 279 potential studies were identified, of these, eight trials met the criteria for inclusion (see Fig. 1). Study details for the eight included studies are shown in Table 1; the main outcomes are presented in Table 2.
Table 1
Characteristics of included studies
Authors, year
Study location/name
Study design
Intervention duration
Number of subjects (men/women)
Inclusion criteria
Type of intervention
Type of dietary intervention
Type of exercise intervention
Method of physical activity measurement
Lindström et al. 2003 [21]
Finland/Finnish Diabetes Prevention Study
RCT
3 years
522 (172/350)
IGT (WHO criteria, 1985), age 40–64 years, BMI≥25 kg/m2
Exercise and diet
Weight reduction through a healthy diet
Participants individually encouraged to increase their overall level of physical activity. Circuit-type exercise sessions were also offered.
Self-report—Kuopio 12 month leisure time physical activity questionnaire
Knowler et al. 2002 [12]
USA/Diabetes Prevention Research Group
RCT
Average follow-up 2.8 (range 1.8–4.6) years
2,161 (680/1481)a
IGT (ADA criteria, 1997), age ≥25 years, BMI ≥24 kg/m2 (≥22 kg/m2 if Asian), fasting plasma glucose ≥5.3 mmol/l
Exercise and diet
Weight reduction through a healthy, low-energy, low-fat diet
Participants individually encouraged to accumulate at least 150 min/week of moderate intensity exercise.
Self-report—Modified Activity Questionnaire and activity log
Pan et al. 1997 [10]
China/The Da Qing IGT and Diabetes Study
RCT
6 years
530 (283/247)
IGT (WHO criteria, 1985), age ≥25 years
1. Exercise 2. Exercise and diet
Weight maintenance for those with a BMI <25 kg/m2 through a healthy energy-balanced diet; weight reduction for those with a BMI ≥25 kg/m2 through reduced energy intake
Participants were encouraged to increase their physical activity to 1 unit per dayb. Those who were aged <50 years and were able to were encouraged to accumulate 2 units per day.
Self-report—type not reported
Eriksson and Lindgärde, 1991 [24]
Sweden/The 6-year Malmö feasibility study
Non-randomised controlled trial
5 years
260 (260/0)
IGT (2-h post-challenge glucose values 7–11 mmol/l, and fasting plasma glucose <7.8 mmol/l)
Exercise and diet
Healthy dietary advice given
Participants were encouraged to increase their physical activity levels. Participants given the option of training in organised groups for a 6-month period in the first year.
VO2max—heart rate response to submaximal workload using bicycle ergometer
Oldroyd et al. 2006 [19]
England
RCT
2 years
69 (39/30)
IGT (WHO criteria, 1985)
Exercise and diet
Weight reduction through a healthy, low-energy, low-fat diet
Participants were encouraged to undertake 20–30 min of aerobic activity 2–3 days/week. In addition, all participants were given a discount at local gyms.
Cardiovascular fitness—shuttle test
Self-report—type not reported
Mensink et al. 2003 [22]
Netherlands/Study on lifestyle-intervention and impaired glucose tolerance Maastricht
RCT
2 years
114 (64/50)
IGT (2-h post-challenge glucose values 7.8–12.5 mmol/l, and fasting plasma glucose <7.8 mmol/l), age >40 years, BMI ≥25.0 kg/m2
Exercise and diet
Weight reduction through a healthy, low-energy, low-fat diet
Participants were encouraged through goal setting to undertake 30 min of moderate intensity exercise per day and were given use of free exercise classes.
VO2max—incremental exhaustive test using bicycle ergometer
Lindahl et al. 1999 [23]
Sweden
RCT
1 year
186 (69/117)
IGT (WHO criteria, 1985), age 30–60 years, BMI ≥27 kg/m2
Exercise and diet
Weight reduction through a healthy, low-energy, low-fat diet.
Participants were encouraged to increase their physical activity. Supervised exercise sessions were available in the first month
VO2max—heart rate response to submaximal and maximal workload using bicycle ergometer
Carr et al. 2005 [20]
USA
RCT
2 years
62 (29/33)
IGT (WHO criteria, 1998)
Structured exercise and diet
Participants were encouraged to follow the energy-balanced American Heart Foundation Step 2 diet
Walking/jogging at >70% of heart rate reserve for 1 h on 3 days/week
VO2max—modified branching treadmill protocol
VO2max, maximal oxygen consumption
aData for lifestyle and control groups only
b1 unit = 30 min of mild exercise, or 20 min of moderate exercise, or 10 min of strenuous exercise, or 5 min of very strenuous exercise
Table 2
Baseline values and change in main outcomes
Authors, year
Baseline VO2max (l/min)
Change in VO2max (l/min)a
Baseline self-reported physical activity levels
Change in self-reported leisure time physical activitya
Baseline body mass (kg)
Change in body mass (kg)a
Baseline 2-h plasma glucose (mmol/l)
Change in 2-h plasma glucose from baseline (mmol/l)a
Baseline fasting glucose (mmol/l)
Change in fasting plasma glucose (mmol/l)a
Relative risk of diabetes in the intervention group vs the C: group (95% CIs)
Lindström et al. 2003 [21]
N/A
N/A
L: 156 (62 to 288) min/week
L: 61 (−33 to 168) min/weekb`
L: 86.7 ± 0.8
Results at 3 years
L: 8.9 ± 0.1
Change at 1 year
L: 6.1 ± 0.05
Change at 1 year
0.4 (0.3–0.7)
C: 169 (65 to 352) min/week
C: 6 (−91 to 104) min/week
C: 85.5 ± 0.9
L: −3.5 ± 0.3b
C: 8.9 ± 0.1
L: −0.9 ± 0.1b
C: 6.2 ± 0.04
L: −0.2 ± 0.04
C: −0.9 ± 0.4
C: −0.3 ± 0.1
C: 0.0 ± 0.04
Change at 3 years
Change at 3 years
L: −0.5 ± 0.2
L: 0.0 ± 0.05
C: −0.1 ± 0.2
C: 0.1 ± 0.05
Knowler et al. 2002 [12]
N/A
N/A
L: 15.5 ± 0.7 MET-h/week
L: 6 MET-h/weekb,c
L: 94.1 ± 0.6
L: −5.6b
L: 9.1 ± 0.03
NR
L: 5.9 ± 0.01
NR
0.4 (0.3–0.5)
C: 17.0 ± 0.9 MET-h/week
C: 1 MET-h/weekc
C: 94.3 ± 0.6
C: −0.1
C: 9.1 ± 0.03
C: 5.9 ± 0.02
Pan et al. 1997 [10]
N/A
N/A
E: 3.4 ± 0.2 unitsd
E: 0.6 unitsd
NR
D&E: −2.5
E: 8.8 ± 0.1
E: 1.7
E: 5.6 ± 0.1
E: 1.3
E: 0.5 (0.2–0.9)
D&E: 3.1 ± 0.2 unitsd
D&E: 0.8 unitsd
E: −0.4
D&E: 9.1 ± 0.1
D&E 1.7
D&E 5.7 ± 0.1
D&E: 1.5
D&E: 0.6 (0.3–0.9)
C: 2.4 ± 0.2 unitsd
C: 0.1 unitsd
C: −1.0
C: 9.0 ± 0.1
C: 4.0
C: 5.5 ± 0.1
C: 2.1
Eriksson and Lindgärde 1991 [24]
L: 2.46 ± 0.04
L: 0.20b
N/A
N/A
L: 82c
L: −3.3b
L: 8.2 ± 01
L: −1.1b
NR
NR
0.4 (0.2–0.7)
C: 2.29 ± 0.1
C: −0.05
C: 83c
C: 0.2
C: 8.3 ± 0.1
C: 0.1c
Oldroyd et al. 2006 [19]
N/A
N/A
NR
NR
L: 85.3 ± 2.9
L: −1.8 ± 1.1b
L: 9.2 ± 0.1
Change at 1 year
L: 6.1 ± 0.1
Change at 1 year
N/A
C: 85.5 ± 2.5
C: 1.5 ± 0.5
C: 9.2 ± 0.2
L: −0.6 ± 0.3
C: 6.2 ± 0.2
L: 0.0 ± 0.1
C: 0.2 ± 0.3
C: 0.1 ± 0.2
Change at 2 years
Change at 2 years
L: 0.2 ± 0.3
L: 0.3 ± 0.1
C: −0.5 ± 0.4
C: 0.1 ± 0.2
Mensink et al. 2003 [22]
L: 2.15 ± 0.1
L: 0.09 ± 1.90b
N/A
N/A
L: 86 ± 1.9
L: −2.4 ± 0.7b
L: 8.9 ± 0.3
Change at 1 year
L: 5.9 ± 0.1
Change at 1 year
N/A
 
C: 2.13 ± 0.1
C: −0.03 ± 2.77
  
C: 83.7 ± 1.5
C: 0.1 ± 0.5
C: 8.6 ± 0.2
L: −0.9 ± 0.3b
C: 5.8 ± 0.1
L: −0.1 ± 0.1
 
        
C: 0.3 ± 0.3
 
C: 0.1 ± 0.1
 
        
Change at 2 years
 
Change at 2 years
 
        
L: −0.6 ± 0.3b
 
L: 0.2 ± 0.1
 
        
C: 0.8 ± 0.4
 
C: 0.5 ± 0.1
 
Lindahl et al. 1999 [23]
L: 2.12 ± 0.1e
L: 0.21 ± 0.1b,e
N/A
N/A
L: 86.4 ± 1.1
L: −5.4 ± 0.5b
L: 7.5
L: −0.7 ± 0.2
L: 5.4
L: −0.5 ± 0.1
N/A
C: 1.89 ± 0.1e
C: −0.02 ± 0.1e
C: 83.6 ± 1.1
C: −0.5 ± 0.3
C: 8.0
C: −0.3 ± 0.3
C: 6.1
C: −0.3 ± 0.1
Carr et al. 2005 [20]
E: 1.93 ± 0.1
E: 0.16 ± 0.04b
N/A
N/A
E: 66.5 ± 2.9
E: −1.8 ± 0.5b
E: 9.2 ± 0.2
Change at 6 months
E: 5.3 ± 0.1
Change at 6 months
N/A
C: 2.02 ± 0.1
C: −0.04 ± 0.03
C: 69.7 ± 2.6
C: 0.6 ± 0.5
C: 9.1 ± 0.2
E: −0.7
C: 5.4 ± 0.1
E: 0.0
C: −0.1
C: 0.1
Change at 2 years
Change at 2 years
E: −0.6
E: 0.0
C: 0.0
C: 0.1
Data are presented as means±SD or medians (interquartile range)
aChange from baseline values reflect results at final follow-up, unless stated otherwise
b p < 0.05 vs C:
cValue estimated from graph
d1 unit = 20 min of moderate E: or 10 min of strenuous E:
eFitness measurement taken in a randomly selected subgroup, n = 45
C control, D diet, E exercise, L lifestyle, MET-h/week metabolic equivalent per week, NR not reported, N/A not applicable
Study design
Seven of the eight trials involved randomisation of subjects to a treatment group or control group [10, 12, 1923]. The non-randomised trial identified control participants by using individuals who, for various (unstated) reasons, were not enrolled in the intervention programme [24].
Sample size
Sample size ranged from 62 to 2,161. Two studies reported a power calculation based on the expected difference in the incidence of diabetes between groups [12, 21], and one reported a power calculation based on the expected difference between groups in the proportion of individuals with IGT at the end of the study [19]. In the latter study, Oldroyd et al. calculated that a total of 100 participants were required to detect a 0.6 mmol/l difference in fasting glucose and a 20% difference in the number of individuals with IGT, allowing for a 90% power at a significance of 0.05. Three studies had sample sizes of fewer than 100 participants at follow-up [19, 20, 22].
Inclusion criteria
All studies examined in this review included individuals with IGT and excluded those with isolated IFG [10, 12, 1924].
Sex
Except for one trial that involved only men (n = 188) [24], all trials included both men and women. In the included studies a total of 40% of participants were men.
Intervention conditions
Seven of the eight included studies used a multi-component lifestyle intervention [10, 12, 19, 2124], and one used a structured gym-based exercise training intervention [20].
Six of the lifestyle intervention studies were based on encouraging individuals to increase their physical activity to approximately 150 min of exercise of moderate to vigorous intensity per week whilst also encouraging weight loss through a healthy energy-restricted diet [10, 12, 19, 21, 22, 24]. Participants in all six studies received regular encouragement and counselling from a trained dietician at least once every 3 months throughout the duration of the intervention. Two of the six studies also provided participants with the option of attending supervised exercise classes for some or all of the study duration [21, 24] and one provided discounted access to local gyms [19]. One study determined the effect of diet and exercise separately and in combination [10].
One lifestyle intervention included an initial 1-month stay at a wellness centre where individuals were provided with healthy dietary options and encouraged to take part in 2.5 h/day of light to moderate intensity exercise using the leisure facilities provided [23]. After the stay at the wellness centre, participants were encouraged to make plans about how they could incorporate healthier habits into everyday life and then received no further contact until follow-up.
The structured exercise intervention study used a training protocol of 180 min per week of aerobic exercise at 70% of heart rate reserve [20]. Exercise training was supervised for the first 6 months and both groups were encouraged to eat a healthy energy-balanced diet, with those in the exercise training group also being encouraged to eat a diet with a high percentage of energy from carbohydrate [20].
Outcomes
Four studies included the incidence of diabetes as the main outcome [10, 12, 21, 24], and four used 2-h plasma glucose levels as a direct measure of glucose control [19, 20, 22, 23]. All the studies using the incidence of diabetes as their main outcome were based on a multi-component lifestyle intervention (see intervention conditions).
Incidence of diabetes and physical activity
All four of the intervention studies that measured the incidence of diabetes as their primary outcome found a significant reduction in the incidence of type 2 diabetes in the intervention group. Diabetes incidence was reduced by 42–63% in this group compared with the control group (see Table 2). The study that investigated the effect of diet and physical activity both separately and in combination found a greater reduction in the incidence of diabetes (46% reduced risk) in the physical activity-only group than in either the combined physical activity and diet group (42% reduced risk) or the diet-only group (13% reduced risk), although the difference between groups was not statistically significant [10]. Three of these four studies relied on self-reported measures of physical activity [10, 12, 21], and of these, only the Diabetes Prevention Program (DPP) [12] and the Finnish Diabetes Prevention Study (FDPS) [21] reported using a validated physical activity questionnaire. All three of the studies relying on self-reported physical activity levels reported non-significant to small changes in physical activity levels in the intervention group. For example, the DPP reported a mean increase in energy expenditure due to leisure time physical activity of around six metabolic equivalent hours per week [12], which is approximately equivalent to walking at a moderate pace for 15 min/day [25]. The FDPS reported no significant change in total physical activity levels compared with the control group and an increase of 9 min/day in moderate to vigorous physical activity [21], and the Da Qing IGT and Diabetes Study reported no significant change in physical activity levels compared with the control group [10]. The Malmö Feasibility Study, which used an objective outcome measure (cardiovascular fitness), reported an 8% increase in maximal oxygen uptake [24].
2-h post-challenge plasma glucose and physical activity
Three of the studies that used the incidence of diabetes as their primary outcome measure also measured 2-h plasma glucose before and after the intervention [10, 21, 24]. The FDPS reported a 0.9 mmol/l decrease in 2-h plasma glucose after 1 year, but no significant change after 3 years [21]; the Da Qing IGT and Diabetes Study found that 2-h plasma glucose increased in all groups, but the increase in the control group was over twice that in either of the intervention groups [10]; and the Malmö Feasibility Study reported a 1.1 mmol/l reduction in 2-h plasma glucose in the intervention group [24]. Of the three lifestyle intervention studies that used 2-h plasma glucose levels rather than the incidence of diabetes as the primary indictor of improved glucose tolerance [19, 22, 23], only one reported a significant difference between the groups in terms of 2-h plasma glucose at follow-up [22]. Two of the studies used a measure of cardiovascular fitness as an indicator of physical activity levels [22, 23], and one [19] used distance walked in a shuttle test [26] as a measure of physical activity. Two studies found a small to moderate increase in cardiovascular fitness (<10% increase compared with baseline value) [22, 23], and the study using the shuttle test reported no change in the distance walked during the test [19]. Similarly, the moderate increases in cardiovascular fitness observed in the structured exercise training study were not associated with significant improvements in 2-h plasma glucose compared with the control group [20].
Fasting glucose
None of the included studies reported a significant change in fasting glucose in the intervention group compared with the control group at follow-up. One study did not report fasting glucose values [24].

Discussion

Eight controlled trials in individuals with IGT were included in this review. Four studies measured the incidence of diabetes as a primary outcome measure, and found that the risk of diabetes was reduced by approximately 50% (range 42–63%) in individuals who were encouraged to reduce their body mass through changes in diet and physical activity [10, 12, 21, 24]. Although the promotion of physical activity was an important component of these studies, the effect of exercise independent of other factors on the risk of diabetes in individuals with IGT is still unclear. All but one [10] of the studies included in this review reported significant weight loss among participants. Given that weight loss is known to improve many of the factors associated with IGT, including insulin sensitivity and glycaemic control [27], and considering only modest increases in physical activity were found in these studies, the success of these interventions is likely to be largely explained by weight loss. The apparent success of the exercise-only intervention in the Da Qing IGT and Diabetes Study [10] is likely to be attributable, at least in part, to the significantly higher levels of physical activity at baseline in the exercise intervention group compared with the control group. The separation of physical activity and weight loss may seem an overcorrection given that increased physical activity may encourage weight loss through increased energy expenditure; however, several meta-analyses of controlled trials investigating the effect of physical activity on glycaemic control in individuals with diabetes found that exercise training was not associated with weight loss [28, 29]. Furthermore it is increasingly recognised that at least 60 min/day of moderate intensity exercise should be undertaken for the effective management of body mass [30], an amount that none of the interventions included in this review achieved.
Three of the four studies that investigated the effect of a lifestyle intervention in individuals with IGT on the incidence of type 2 diabetes [1012] relied on self-reported measures of physical activity. Given the limitations of subjective measures of physical activity, particularly when measuring non-structured forms of moderate physical activity such as walking activity [31], these lifestyle intervention studies provide uncertain information about the effect of physical activity in individuals with IGT.
Results from the lifestyle intervention studies that relied on changes in 2-h plasma glucose rather than the incidence of diabetes as the primary measure of glucose control were inconclusive [19, 20, 23]. Two of the three studies were unsuccessful at improving glucose tolerance [19, 23]. Similarly, the one study that used an aerobic exercise training protocol found no improvements in glucose tolerance as measured by 2-h plasma glucose [20]. However, it did find a significant improvement in insulin sensitivity at both 6 and 24 months. This suggests that, although the intervention goal of 3 h/week of moderate intensity exercise was enough to improve insulin sensitivity, it was not long enough and/or of sufficient intensity to elicit the necessary magnitude of change in insulin sensitivity for this to be translated into a significant reduction in 2-h plasma glucose.
Overall, non-significant results were seen in all but two of the studies that measured 2-h plasma glucose before and after the intervention. However, despite the link between 2-h plasma glucose and diabetes risk, it does not follow that the risk of diabetes was unchanged in these studies, as demonstrated by the FDPS, which reported a non-significant change in 2-h plasma glucose over the course of the intervention but a >50% reduction in the risk of diabetes [21]. One reason for this discrepancy is likely to be the poor repeatability of 2-h plasma glucose values [32], and given the relatively small sample sizes in most of these studies, it is possible that improvements in glucose tolerance were not detected using 2-h plasma glucose. The glucose AUC has been identified as a more reliable measure of glucose tolerance than 2-h plasma glucose [33], and is therefore a more sensitive measure of glucose tolerance. One study included in this review measured both 2-h plasma glucose and glucose AUC at baseline and follow-up [20]. It reported that, although 2-h plasma glucose did not change significantly at any of the follow-up time points, there was a significant reduction in the glucose AUC at 6 months, and a trend towards significance at 24 months.
Given the failure of the lifestyle interventions to substantially increase physical activity levels, and the inconclusive result of the structured exercise training study, the role of physical activity independent of other lifestyle changes in the treatment of prediabetes remains equivocal. However, statistical analysis of the independent effects of physical activity, which has been carried out on some of the lifestyle intervention studies included in this review, show interesting results. For example, the conclusion of the Malmö Feasibility Study that cardiovascular fitness and weight loss were equally correlated to improved glucose tolerance is supported by data from the Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM) [34], and a recent analysis of data from the FDPS found a 49% difference in the risk of diabetes, after adjustment for changes to body mass and diet, when comparing those in the highest and lowest tertiles of moderate to vigorous leisure time physical activity change [35]. Thus, although the overall evidence for the independent effect of physical activity in the management of prediabetes is equivocal, encouraging evidence is starting to emerge in support of the importance of exercise.
Given the limitations of the studies included in this review it is not possible to make any recommendations as to the intensity and duration of exercise needed to improve glucose tolerance and/or reduce the risk of diabetes in individuals with IGT, independently of other lifestyle changes. The equivocal nature of the evidence is reflected in the advice given by the ADA, which recommends that individuals with IGT should include 150 min/week of moderate to vigorous intensity exercise as part of a weight management programme [36]. However, the aforementioned analysis of the change in physical activity in the FDPS found that a difference of 246 min/week in median values between those in the lowest and the highest tertiles of moderate to vigorous physical activity change was associated with a significant reduction in the risk of diabetes, after adjusting for changes in diet and body mass. However, the difference of 120 min/week in median values between the lowest and middle tertiles was not associated with a reduced risk of diabetes [35]. Although this result was obtained by analysing the pooled cohort, and therefore provides little information about the effectiveness of the intervention itself, it does suggest that 150 min/week of moderate to vigorous intensity exercise is unlikely to be enough to significantly reduce the risk of type 2 diabetes in individuals with IGT, independently of other lifestyle changes. However, given that this analysis relied on self-reported physical activity levels, further rigorous studies are needed to confirm this.
All studies included in this review selected individuals using IGT as an inclusion criteria. Therefore, any conclusions from this review can only be applied to individuals with IGT and it is impossible to determine whether or not exercise may be effective in treating individuals with isolated IFG. However as individuals with isolated IFG account for a minority of individuals with prediabetes [37], conclusions about the effect of exercise on IGT drawn from this review will apply to the majority of individuals with prediabetes.
In summary, the majority of studies identified for this review used interventions that encouraged dietary and physical activity to initiate and maintain weight loss in individuals with IGT. Analysis of these studies found that the independent effect of physical activity in reducing the risk of type 2 diabetes in individuals with prediabetes is equivocal. Furthermore, given the limited evidence, no definite conclusion can be drawn either as to the amount of physical activity needed to reduce the risk of diabetes in individuals with prediabetes or the effectiveness of a single-component physical activity intervention compared with more conventional multi-component interventions.
Thus, more evidence from rigorously designed randomised controlled trials with objective measures of physical activity is needed. As the majority of studies promoting lifestyle changes included in this review failed to substantially increase physical activity levels, strategies for effecting increased physical activity in this population also need to be researched thoroughly. Further investigation is also needed into whether exercise is equally effective in treating the different phenotypes of IGT and IFG.

Duality of interest

There was no duality of interest in the writing of this review.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 2.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14(Suppl 5):S1–S85PubMed Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14(Suppl 5):S1–S85PubMed
2.
Zurück zum Zitat Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5–S20
3.
Zurück zum Zitat Edelstein SL, Knowler WC, Bain RP et al (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701–710PubMedCrossRef Edelstein SL, Knowler WC, Bain RP et al (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701–710PubMedCrossRef
4.
Zurück zum Zitat Eschwege E, Richard JL, Thibult N et al (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, ten years later. Horm Metab Res Suppl 15:41–46PubMed Eschwege E, Richard JL, Thibult N et al (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, ten years later. Horm Metab Res Suppl 15:41–46PubMed
5.
Zurück zum Zitat Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O’Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823–829PubMed Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O’Leary DH, Savage PJ (2000) Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 20:823–829PubMed
6.
Zurück zum Zitat Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19:708–723PubMedCrossRef Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19:708–723PubMedCrossRef
7.
Zurück zum Zitat Kriska AM, Blair SN, Pereira MA (1994) The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence. Exerc Sport Sci Rev 22:121–143PubMedCrossRef Kriska AM, Blair SN, Pereira MA (1994) The potential role of physical activity in the prevention of non-insulin-dependent diabetes mellitus: the epidemiological evidence. Exerc Sport Sci Rev 22:121–143PubMedCrossRef
8.
Zurück zum Zitat Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH (1992) A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 268:63–67PubMedCrossRef Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH (1992) A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 268:63–67PubMedCrossRef
9.
Zurück zum Zitat Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797PubMedCrossRef Hu FB, Manson JE, Stampfer MJ et al (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797PubMedCrossRef
10.
Zurück zum Zitat Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20:537–544PubMedCrossRef Pan XR, Li GW, Hu YH et al (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care 20:537–544PubMedCrossRef
11.
Zurück zum Zitat Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350PubMedCrossRef
12.
Zurück zum Zitat Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef Knowler WC, Barrett-Connor E, Fowler SE et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef
13.
Zurück zum Zitat Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67:152–162PubMedCrossRef Kosaka K, Noda M, Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67:152–162PubMedCrossRef
14.
Zurück zum Zitat Ramachandran A, Snehalatha C, Mary S et al (2006) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297PubMedCrossRef Ramachandran A, Snehalatha C, Mary S et al (2006) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49:289–297PubMedCrossRef
15.
Zurück zum Zitat WHO Study Group on Diabetes (1985) Diabetes mellitus: report of a WHO study group. WHO technical report series no. 727. WHO, Geneva WHO Study Group on Diabetes (1985) Diabetes mellitus: report of a WHO study group. WHO technical report series no. 727. WHO, Geneva
16.
Zurück zum Zitat Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553PubMedCrossRef
17.
Zurück zum Zitat Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
18.
Zurück zum Zitat Genuth S, Alberti KG, Bennett P et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef Genuth S, Alberti KG, Bennett P et al Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167PubMedCrossRef
19.
Zurück zum Zitat Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG (2006) Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract 72:117–127PubMedCrossRef Oldroyd JC, Unwin NC, White M, Mathers JC, Alberti KG (2006) Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract 72:117–127PubMedCrossRef
20.
Zurück zum Zitat Carr DB, Utzschneider KM, Boyko EJ et al (2005) A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. Diabetes 54:340–347PubMedCrossRef Carr DB, Utzschneider KM, Boyko EJ et al (2005) A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function. Diabetes 54:340–347PubMedCrossRef
21.
Zurück zum Zitat Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230–3236PubMedCrossRef Lindström J, Louheranta A, Mannelin M et al (2003) The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26:3230–3236PubMedCrossRef
22.
Zurück zum Zitat Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ (2003) Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res 11:1588–1596PubMedCrossRef Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ (2003) Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res 11:1588–1596PubMedCrossRef
23.
Zurück zum Zitat Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G (1999) Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246:105–112PubMedCrossRef Lindahl B, Nilsson TK, Jansson JH, Asplund K, Hallmans G (1999) Improved fibrinolysis by intense lifestyle intervention. A randomized trial in subjects with impaired glucose tolerance. J Intern Med 246:105–112PubMedCrossRef
24.
Zurück zum Zitat Eriksson KF, Lindgärde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. the 6-year Malmö feasibility study. Diabetologia 34:891–898PubMedCrossRef Eriksson KF, Lindgärde F (1991) Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. the 6-year Malmö feasibility study. Diabetologia 34:891–898PubMedCrossRef
25.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports 32:498S–516S Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports 32:498S–516S
26.
Zurück zum Zitat Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE (1992) Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47:1019–1024PubMedCrossRef Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE (1992) Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47:1019–1024PubMedCrossRef
27.
Zurück zum Zitat American Diabetes Association (2002) Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25:202–212CrossRef American Diabetes Association (2002) Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 25:202–212CrossRef
28.
Zurück zum Zitat Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227PubMedCrossRef Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227PubMedCrossRef
29.
Zurück zum Zitat Thomas DE, Elliott E, Naughton G (2006) Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 3:CD002968PubMed Thomas DE, Elliott E, Naughton G (2006) Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 3:CD002968PubMed
30.
Zurück zum Zitat Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B (2004) Chronicle of the institute of medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79:921S–930SPubMed Brooks GA, Butte NF, Rand WM, Flatt JP, Caballero B (2004) Chronicle of the institute of medicine physical activity recommendation: how a physical activity recommendation came to be among dietary recommendations. Am J Clin Nutr 79:921S–930SPubMed
31.
Zurück zum Zitat Cooper AR (2003) Objective measurement of physical activity. In: MeKenna J, Riddoch C (eds) Perspectives on health and exercise. Palgrave and Macmillian, London, pp 83–108 Cooper AR (2003) Objective measurement of physical activity. In: MeKenna J, Riddoch C (eds) Perspectives on health and exercise. Palgrave and Macmillian, London, pp 83–108
32.
Zurück zum Zitat Ko GT, Chan JC, Woo J et al (1998) The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 35:62–67PubMed Ko GT, Chan JC, Woo J et al (1998) The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 35:62–67PubMed
33.
Zurück zum Zitat Feskens EJ, Bowles CH, Kromhout D (1991) Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 44:947–953PubMedCrossRef Feskens EJ, Bowles CH, Kromhout D (1991) Intra- and interindividual variability of glucose tolerance in an elderly population. J Clin Epidemiol 44:947–953PubMedCrossRef
34.
Zurück zum Zitat Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE (2003) Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord 27:377–384PubMedCrossRef Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE (2003) Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year. Int J Obes Relat Metab Disord 27:377–384PubMedCrossRef
35.
Zurück zum Zitat Laaksonen DE, Lindström J, Lakka TA et al (2005) Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 54:158–165PubMedCrossRef Laaksonen DE, Lindström J, Lakka TA et al (2005) Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 54:158–165PubMedCrossRef
36.
Zurück zum Zitat Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:1433–1438PubMedCrossRef Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD (2006) Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 29:1433–1438PubMedCrossRef
37.
Zurück zum Zitat Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM (2003) Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 26:645–649PubMedCrossRef Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM (2003) Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 26:645–649PubMedCrossRef
Metadaten
Titel
The role of physical activity in the management of impaired glucose tolerance: a systematic review
verfasst von
T. Yates
K. Khunti
F. Bull
T. Gorely
M. J. Davies
Publikationsdatum
01.06.2007
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 6/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0638-8

Weitere Artikel der Ausgabe 6/2007

Diabetologia 6/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.